Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults With Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated With Supplemental Ceftaroline

Infectious Diseases and Therapy - United States
doi 10.1007/s40121-019-00277-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ceftobiprole- And Ceftaroline-Resistant Methicillin-Resistant Staphylococcus Aureus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Ceftaroline in the Treatment of Methicillin-Resistant and Daptomycin-Non-Susceptible Staphylococcus Aureus Bacteremia and Infective Endocarditis in End-Stage Renal Disease

The Southwest Respiratory and Critical Care Chronicles
2013English

Predictors of Relapse of Methicillin-Resistant Staphylococcus Aureus Bacteremia After Treatment With Vancomycin

Journal of Clinical Microbiology
Microbiology
2011English

Ceftaroline-Fosamil Efficacy Against Methicillin-Resistant Staphylococcus Aureus in a Rabbit Prosthetic Joint Infection Model

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Vancomycin Plus Nafcillin Salvage for the Treatment of Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia Following Daptomycin Failure: A Case Report and Literature Review

Therapeutic Advances in Infectious Disease
2018English

Case Report of a Successful Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia and MRSA/Vancomycin-Resistant Enterococcus Faecium Cholecystitis by Daptomycin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Impact of EUCAST Ceftaroline Breakpoint Change on the Susceptibility of Methicillin-Resistant Staphylococcus Aureus Isolates Collected From Patients With Complicated Skin and Soft Tissue Infections

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus Aureus Infections

Archives of Internal Medicine
2006English

Vancomycin Bactericidal Activity as a Predictor of 30-Day Mortality in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy